Lucy Scientific Discovery (LSDI) Short Interest Ratio & Short Volume

Short interest is the volume of Lucy Scientific Discovery shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 2,700 shares of LSDI short. 0.24% of Lucy Scientific Discovery's shares are currently sold short. Learn More on Lucy Scientific Discovery's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.24% of Lucy Scientific Discovery's floating shares are currently sold short.

Lucy Scientific Discovery saw a decrease in short interest in June. As of June 15th, there was short interest totaling 2,700 shares, a decrease of 82.9% from the previous total of 15,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Lucy Scientific Discovery currently has issued a total of 1,765,000 shares. Some of Lucy Scientific Discovery's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lucy Scientific Discovery currently has a public float of 1,110,000 shares.

0.24% of Lucy Scientific Discovery's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lucy Scientific Discovery: Titan Pharmaceuticals, Inc. (1.56%), Gritstone bio, Inc. (6.83%), Synaptogenix, Inc. (0.41%), Oncternal Therapeutics, Inc. (1.71%), Lixte Biotechnology Holdings, Inc. (24.89%), Purple Biotech Ltd (1.08%), NuCana plc (3.01%), InMed Pharmaceuticals Inc. (16.04%), Palisade Bio, Inc. (3.29%), Revelation Biosciences, Inc. (1.10%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($5.04 billion), T-Mobile US, Inc. ($4.49 billion), Charter Communications, Inc. ($3.25 billion), Moderna, Inc. ($3.02 billion), General Motors ($2.91 billion), Royal Caribbean Cruises Ltd. ($2.37 billion), Cencora, Inc. ($2.19 billion), Tractor Supply ($1.82 billion), Williams-Sonoma, Inc. ($1.72 billion), and Enphase Energy, Inc. ($1.61 billion). View all of the most shorted stocks.

Short selling LSDI is an investing strategy that aims to generate trading profit from Lucy Scientific Discovery as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lucy Scientific Discovery occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LSDI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSDI, twice per month. The most recent reporting period available is June, 15 2024.